Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Robin Jodi F.General Counsel and Secretary | Tax withholding | F | $84K 2,388 sh | Mar 16, 2026 |
| 16 | Hernandez Steven DennisChief Human Resources Officer | Tax withholding | F | $105K 2,858 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 16 | Nichols Brian WGroup VP & Controller | Tax withholding | F | $57K 755 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 16 | Watson Michael JamesEVP, Head of Axos Securities | Disposition to issuer | D | $52K 610 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 16 | Gill AnnSVP, Chief Accounting Officer | Option exercise | M | $65K 773 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 16 | Sousa BenChief Information Officer | Tax withholding | F | $90K 718 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 15 | Adamson Philip B.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $9,973 1,262 sh | Mar 16, 2026 traded Mar 2, 2026 |
| 15 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | $6.70M 112.4K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | Walsh Mark T.Director, CEO & Director | Option exercise | M | $269K 33.5K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | $6.70M 112.4K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | $4.69M 78.7K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $30K 306 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $363K 8,303 sh | Mar 16, 2026 traded Mar 11, 2026 |
| 15 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | $4.69M 78.7K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | — 112.4K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Tanious Jubran N.President & COO | Grant or award | A | $1.20M 153.5K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | — 78.7K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $79K 804 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 14 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | — 5,191 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | — 23.9K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $170K 1,703 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 13 | Parrish DeanEVP & Chief Operating Officer | Option exercise | M | — 3,197 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Watson Michael JamesEVP, Head of Axos Securities | Option exercise | M | — 1,349 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 13 | Simhambhatla RaviEVP, CDIO - see remarks | Option exercise | M | — 2,394 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Fuchsen Matthew RChief Development Officer | Grant or award | A | — 2,345 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 13 | Kelley Joseph MichaelSenior Vice President | Grant or award | A | — 2,941 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Doucet Terrence Gregory JosephSee Remarks | Option exercise | M | — 23.8K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Fielkow Jeffrey ADirector | Grant or award | A | — 2,853 sh | Mar 16, 2026 traded Mar 14, 2026 |
| 13 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $915K 22.2K sh | Mar 16, 2026 traded Mar 13, 2026 |
| 13 | O'Brien JennieSVP, Chief Accounting Officer | Grant or award | A | — 9,917 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Crow David MEVP, Head of Axos Clearing | Option exercise | M | — 738 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 13 | Watson Michael JamesEVP, Head of Axos Securities | Option exercise | M | — 1,105 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 13 | Cerwin Brittany CChief Accounting Officer | Grant or award | A | — 1,807 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 13 | Shaffer Megan N.Group Vice President | Grant or award | A | — 3,002 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Zalatoris TimmiChief Human Resources Officer | Grant or award | A | — 1,908 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Shaub MatthewExecutive Vice President | Tax withholding | F | $10K 114 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Doucet Terrence Gregory JosephSee Remarks | Tax withholding | F | $43K 12.2K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Wise James MichaelSVP & Chief Accounting Officer | Tax withholding | F | $6,123 942 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 13 | Kelley Joseph MichaelSenior Vice President | Grant or award | A | — 6,404 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Bothwick Jay EDirector | Option exercise | M | — 625 sh | Mar 16, 2026 traded Mar 14, 2026 |